טוען...

Inhibition of the covalent binding reaction of complement component C4 by penicillamine, an anti-rheumatic agent.

D(-)-Penicillamine [D(-)-beta beta-dimethylcysteine] is an anti-arthritic drug, but its use is limited by adverse side effects, which include problems in immune-complex clearance. Complement is important as a source of inflammatory mediators in rheumatoid arthritis and is also involved in immune-com...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Sim, E, Dodds, A W, Goldin, A
פורמט: Artigo
שפה:Inglês
יצא לאור: 1989
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1138525/
https://ncbi.nlm.nih.gov/pubmed/2785792
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!